NYSE:MYOV - Myovant Sciences Ltd.
$8.27
 $-0.14
-1.66%
12:55PM EDT
2019-07-22
Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for womens health diseases and other endocrine-related disorders. Its main product candidate is Relugolix. Relugolix is an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone (GnRH) receptor antagonist that binds to and inhibits receptors in the anterior pituitary gland. Inhibition of GnRH receptors decreases the release of the gonadotropins, luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH, thereby decreasing the down-stream production of estrogen and progesterone by the ovaries in women and testosterone by the testes in men. It is advancing relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids, endometriosis-associated pain and prostate cancer. It intends to develop its second product candidate, RVT-602, for the treatment of female infertility as part of assisted reproduction. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MYOV     avg for
industry  
  avg for
sector  
42 stocks weight:  28. 58   217. 37   399. 45  
42 stocks rank:  2. 90 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 70   2. 10   2. 04  

quick ratio:  2. 18   5. 49   1. 88  
current ratio:  2. 32   5. 87   2. 36  

target price low:  25. 00   83. 44   114. 90  
target price avg:  8. 75   106. 20   137. 90  
target price high:  9. 55   132. 30   158. 97  
1-yr high:  26. 78   111. 86   142. 57  
last close:  8. 41   86. 79   125. 44  
50-day avg:  10. 34   86. 68   122. 63  
200-day avg:  17. 63   89. 22   121. 38  
1-yr low:  8. 35   69. 78   100. 51  
volume:  137. 16 K 2. 62 M 3. 43 M
50-day avg volume:  368. 46 K 3. 20 M 4. 16 M
200-day avg volume:  147. 43 K 2. 99 M 4. 75 M

1-day return:  -3. 00 % -1. 30 % -0. 99 %
this week return:  -2. 10 % 0. 45 % -0. 20 %
12-wk return:  -52. 19 % 0. 94 % 4. 84 %
52-wk return:  -56. 01 % -1. 30 % 10. 55 %

enterprise value (EV):  550. 50 M 45. 10 B 122. 38 B
market cap:  753. 73 M 38. 96 B 108. 40 B
EBITDA:  -264. 39 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -2. 08   5. 38   11. 93  
total debt:  99. 38 M 10. 90 B 17. 48 B
debt/equity:  2. 29 K 57. 18   120. 05  
net income (common):  -273. 55 M 2. 07 B 4. 05 B

shares outstanding:  72. 20 M 538. 09 M 1. 24 B
shares:  32. 00 M 548. 00 M 1. 22 B
shares short:  2. 18 M 10. 98 M 11. 87 M
shares short prior month:  2. 41 M 9. 32 M 12. 05 M
short ratio:  4. 25   5. 60   3. 34  
short % of float:  8. 80 % 6. 48 % 2. 64 %
total cash/share:  2. 16   10. 98   9. 19  
total cash:  156. 07 M 5. 93 B 6. 10 B
free cash flow:  -126. 88 M 2. 92 B 4. 55 B
operating cash flow:  -224. 09 M 3. 80 B 5. 78 B

book value:  0. 06   13. 35   27. 45  
price/book:  140. 17   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -4. 09   2. 10   4. 23  
forward EPS:  -3. 40   3. 45   7. 10  
P/E:  -2. 06   1. 90   32. 10  
forward P/E:  -2. 47   6. 46   15. 47  
PE/G:  0. 14   0. 70   -0. 54  
growth:  -14. 79 % 265. 63 % 79. 11 %
earnings high:  -0. 85   0. 89   1. 68  
earnings avg:  -0. 92   0. 70   1. 57  
earnings low:  -0. 98   0. 46   1. 46  
revenue high:  10. 00 M 2. 57 B 11. 07 B
revenue avg:  3. 33 M 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -113. 34 % -2. 34 % 5. 28 %
return on equity:  -1300. 67 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  0. 79   1. 27   0. 91  
sharpe (1yr):  -0. 96   0. 16   0. 77  

held % insiders:  67. 07 % 6. 06 % 3. 29 %
held % institutions:  31. 04 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MYOV
.     109.28 =        109.28 :: --> INITIAL WEIGHT <--
.    - 4.088 =       105.192 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.016 =        212.02 :: P/E factor
.    x 1.637 =       347.178 :: PE/G factor
.    x 1.622 =       563.164 :: beta factor
.    x 0.987 =       555.612 :: sharpe factor
.    x 2.395 =       1330.61 :: current ratio factor
.     x 1.36 =      1809.992 :: quick ratio factor
.    x 1.111 =      2011.694 :: short ratio factor
.    x 1.542 =      3101.138 :: price-to-book factor
.    x 2.787 =      8644.408 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     18332.999 :: sector+industry 1-year gains factor
.    x 1.009 =     18505.844 :: industry 12-weeks return factor
.    x 1.308 =     24203.582 :: industry 2-weeks return factor
.     x 0.87 =     21063.942 :: company one-year gains+dividend factor
.    x 0.978 =     20591.778 :: company 13 weeks' performance factor
.    x 0.979 =     20165.024 :: "drift" penalty 5 days ago
.    / 2.044 =        9866.6 :: overall "drift" factor
.    x 0.696 =      6865.726 :: largest single-day jump factor
.    x 0.114 =       782.865 :: low price factor
.    x 1.535 =      1201.554 :: notable returns + performance factor
.     x 2.78 =      3340.725 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.677 =      2262.902 :: forward EPS factor
.    x 0.883 =      1997.604 :: forward P/E factor
.    x 1.185 =      2366.587 :: industry recommendation factor
.    x 2.442 =       5778.24 :: company recommendation factor
.    x 1.003 =      5794.219 :: factor historical industry gain for week 29
.   x 10.459 =     60602.479 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         15.69 :: reduced for readability
.   + 12.418 =        28.108 :: add/subtract for investor sentiment
.    + 0.471 =        28.578 :: earnings report in 15 days
.                               --> FINAL WEIGHT <--
.                     28.578 :: FINAL WEIGHT for NYSE:MYOV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org